FibroGen
FGEN
FGEN
193 hedge funds and large institutions have $2.47B invested in FibroGen in 2018 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 63 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
193
Holders Change
+6
Holders Change %
+3.21%
% of All Funds
4.43%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
32
Increased
64
Reduced
63
Closed
23
Calls
$22.7M
Puts
$26.4M
Net Calls
-$3.76M
Net Calls Change
-$2.13M
Top Buyers
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
$40.2M |
| 2 |
PC
PointState Capital
New York
|
$19.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$300M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$90.1M |
| 5 |
AG
Artal Group
Luxembourg
|
$11.6M |
Top Sellers
| 1 |
BlackRock
New York
|
$273M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
$37M |
| 3 |
Invesco
Atlanta,
Georgia
|
$201K |
| 4 |
Renaissance Technologies
New York
|
$7.73M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
$3.44M |
